Correlation Between Biotechnology Fund and Goldman Sachs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Goldman Sachs E, you can compare the effects of market volatilities on Biotechnology Fund and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Goldman Sachs.

Diversification Opportunities for Biotechnology Fund and Goldman Sachs

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BIOTECHNOLOGY and Goldman is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Goldman Sachs E in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs E and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs E has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Goldman Sachs go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Goldman Sachs

Assuming the 90 days horizon Biotechnology Fund Class is expected to under-perform the Goldman Sachs. In addition to that, Biotechnology Fund is 4.0 times more volatile than Goldman Sachs E. It trades about 0.0 of its total potential returns per unit of risk. Goldman Sachs E is currently generating about 0.17 per unit of volatility. If you would invest  913.00  in Goldman Sachs E on September 2, 2024 and sell it today you would earn a total of  12.00  from holding Goldman Sachs E or generate 1.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biotechnology Fund Class  vs.  Goldman Sachs E

 Performance 
       Timeline  
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Goldman Sachs E 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Goldman Sachs E has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Goldman Sachs is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Fund and Goldman Sachs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Fund and Goldman Sachs

The main advantage of trading using opposite Biotechnology Fund and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.
The idea behind Biotechnology Fund Class and Goldman Sachs E pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges